Bristol Myers Squibb vs Ipsen
Bristol Myers Squibb vs Ipsen, compared side by side on 17 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Bristol Myers Squibb is on 22/100 and Ipsen on 33/100.
Where each one leads
Bristol Myers Squibb
- headcount: 38,080 against 6,664
- LinkedIn following: 1,886,144 against 317,774
Ipsen
- our overall score: 33/100 against 22/100
At a glance
| Measure | Bristol Myers Squibb | Ipsen |
|---|---|---|
| What it is | A global biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for patients with serious diseases. | Global biopharmaceutical company focused on oncology, rare diseases, and neuroscience. |
| Category | Biotech, MedTech, HealthTech, Drug Discovery | Biotech, MedTech, HealthTech, Genomics |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Software | hardware | services | marketplace | platform |
| Founded | 1989 | 1929 |
| Headquarters | New York, United States | Paris, France |
| Status | Active | Active |
Size, funding and growth
| Measure | Bristol Myers Squibb | Ipsen |
|---|---|---|
| Employees | 38,080 | 6,664 |
| Headcount growthLast 12 months | Not published | +8.0% |
| Open roles | Not published | 100 |
| Latest round | Not published | Grant (prize money) |
| LinkedIn followers | 1,886,144 | 317,774 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Bristol Myers Squibb | Ipsen |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 22/100 | 33/100 |
| Traction | 20/100 | 20/100 |
| Team | 10/100 | 30/100 |
| Community | Not published | 8/100 |
| Search visibility | 23/100 | 39/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (44/100) | D (45/100) |
| Domain ratingLink authority, 0-100 | 83/100 | 76/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Bristol Myers Squibb | Ipsen |
|---|---|---|
| Hosting | Self Managed | Self Managed |
| CDN | CloudFront | Not detected |
| CMS | Not detected | WordPress |
| Frameworks | Not detected | Tailwind CSS, Bootstrap |
| Analytics | Microsoft Clarity, Qualtrics | Jetpack Stats |
What users say
| Measure | Bristol Myers Squibb | Ipsen |
|---|---|---|
| Reddit sentimentThreads we track | 2 positive, 3 negative across 6 threads | Not published |
“Bristol Myers Squibb ist im Kurs gerade günstig und spuckt aktuell über 5% Rendite durch Dividende (vierteljährlich) im Jahr aus. Nichts aufregendes, aber ne solide Bank und nicht vergessen... mühsam ernährt sich das Eichhörnchen.”r/Aktien
Bristol Myers Squibb vs Ipsen: common questions
Which is better, Bristol Myers Squibb or Ipsen?
On our 0-100 score Ipsen rates higher (33/100 against 22/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 17 data points above: read the rows that match what you are buying for.
How do Bristol Myers Squibb and Ipsen compare on the numbers?
Bristol Myers Squibb leads on headcount (38,080 against 6,664), LinkedIn following (1,886,144 against 317,774). Ipsen leads on our overall score (33/100 against 22/100).
What do real users say about Bristol Myers Squibb and Ipsen?
Bristol Myers Squibb: 2 positive and 3 negative mentions across 6 Reddit threads we track, mostly in r/Aktien.
Read the full Bristol Myers Squibb review and pricing or the Ipsen review and pricing. You can also browse other Bristol Myers Squibb alternatives we track.